By TechnologySolid Phase · Liquid Phase · Hybrid and Recombinant
By ApplicationTherapeutics(Metabolic Disorders, Cardiovascular Disorders, Respiratory Disorders, Infectious Diseases, Others) · Diagnosis · Research
By End UserBiopharmaceutical Companies · Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO) · Research Institutes · Others
By GeographyNorth America · Latin America · Europe · Asia Pacific · Middle East & Africa
Published In12 Mar 2026
Report CodeCMI4336
Pages250+
FormatsExcel and PDF
Base Year2025
Estimated Year2026
Historical Range2020 - 2024
Forecast Period2026-2033
Market Segmentation
By Product (Revenue, USD Mn, 2021 - 2033)
Reagents & Consumables
Equipment
Peptide Synthesizers
Lyophilizer
Chromatography Equipment
By Technology (Revenue, USD Mn, 2021 - 2033)
Solid Phase
Liquid Phase
Hybrid and Recombinant
By Application (Revenue, USD Mn, 2021 - 2033)
Therapeutics
Metabolic Disorders
Cardiovascular Disorders
Respiratory Disorders
Infectious Diseases
Others
Diagnosis
Research
By End User (Revenue, USD Mn, 2021 - 2033)
Biopharmaceutical Companies
Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO)